Pub. Date : 2018 May 11
PMID : 29752560
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Based on current literature, for HER2-negative patients with low-risk breast cancer, anthracyclines could be spared with regimens such as cyclophosphamide, methotrexate, and fluorouracil (CMF) or docetaxel and cyclophosphamide (TC). | Anthracyclines | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
2 | For the remaining patients with HER2 overexpression, while docetaxel, carboplatin, and trastuzumab (TCH) has demonstrated to improve disease-free survival (DFS), anthracycline-containing regimens should be discussed, especially for those with very high-risk breast cancer. | Anthracyclines | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |